Krol CG, Klok FA, de Koning EJ
Preparing for medication discontinuation One of the biggest concerns with pharmaceutical GLP-1 medications is what happens when you stop
Professor Carol Pollock, Professor of Medicine at The University of Sydneys Kolling Institute in Sydney, said this was the first trial demonstrating kidney and CV protection from a glucagon-like peptide 1 (GLP-1) receptor agonist
The Cochrane Database of Systematic Reviews , 3, CD005105
Wegovy is also approved for children over 12 years, adolescents, and older adults with obesity
Together, they enhance muscle growth, improve fat metabolism, support bone density, strengthen the cardiovascular system, and boost libido, making them ideal for those looking to optimize their vitality and performance